Sunday November 22, 2009 8:17 AM ET
SmartMoney
Net Asset Value: 
24.72
1-Day Return: 
-0.05 (-0.20%)
YTD Return
as of 11/20/09: 
Up 24.85%
PRHSX 
(T Rowe Price Hlth Scienc)
Classification: Health/Biotech     Objective: Health/Biotech
Open to New Investors: Yes
Lipper Rating
Total Return
Consistent Return
Preservation
Tax Efficiency
Expense
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
NAV Chart | Growth of $10,000
Fund Chart
Total Returns (As of 11/20/2009)
 YTD1Yr3Yr5Yr10Yr
Fund 24.85 52.82 2.23 7.22 8.57
Classification 16.41 37.20 -0.77 3.55 6.13
Index (S&P 500) 23.50 48.80 -5.90 0.70 -0.90
% Rank in Class (1-best,100=worst)2214111121
Fund Stats
Investment Objective:Health/Biotech
Net Assets ($Mil)1,929.90
Inception Date:12/29/95
Manager Name, TenureKris H. Jenner, 2000
Expense Ratio: 0.86%
Sales Charge:
Load Type:
 
No Load
0.00%
0.00%
Top 10 Holdings (As of 9/30/09)
Company NameSymbol% Net Assets
Gilead Sciences Inc GILD 5.55
Alexion Pharm ALXN 3.79
Baxter International Inc BAX 3.26
Medco Health Sol MHS 2.72
Roche Holding Ag RHHVF 2.52
Teva Pharmaceutical Industries Ltd TEVA 2.44
Express Scripts Inc ESRX 2.38
Henry Schein HSIC 2.34
Amgen AMGN 1.98
Vertex Pharma VRTX 1.84
% of Total Holdings 28.82
Advertisements
View Overview for: